Viewing Study NCT04279405


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2025-12-26 @ 2:07 AM
Study NCT ID: NCT04279405
Status: COMPLETED
Last Update Posted: 2024-06-13
First Post: 2020-02-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase Ib Study of YY-20394 in Participants With B-cell Hematologic Malignancies
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module